Herewith a copy of the announcement that you will also find on the National Institute for Health Research (NIHR) and INVOLVE websites to day about the award of the new INVOLVE contract. This means INVOLVE now enters its second decade of being fully funded by the NIHR and the only such body of its kind... Continue Reading →
The following official announcement has just been posted on the NIHR website with links to the terms of reference and initial submission document. I say 'initial' because there will be others ways in which you can contribute to the review over the next few months. I am very excited that NIHR has commissioned this exercise... Continue Reading →
We have had two pieces of good news about health research of patient benefit this week. First, the National Institute for Health and Care Excellence (NICE) issued new guidance saying that tamoxifen or raloxifene taken daily for five years can cut breast cancer risk by 40%. This means women at risk of developing breast cancer have... Continue Reading →
I was delighted to see this getting considerable airtime on the radio this morning: the launch of the London Lung Cancer Alliance with its aim of recruiting 3000 lung patients into clinical trials per year. Lung cancer is on the rise in the UK and it is a difficult condition for which to raise public awareness and... Continue Reading →
Dame Sally Davies, England's new Chief Medical Officer, gives a frank and open interview in today's Financial Times. In it, Dame Sally says that she will continue to play a leadership role with respect to NHS R&D but with perhaps less involvement in the day-to-day running (my interpretation).
The UK National Institute for Health Research (NIHR) has today announced £775 million worth of funding over five years for translational research. The funding will be made available through NIHR to NHS/university partnerships. Also, in what has to be an exemplar for others in terms of dissemination, Diabetes UK have today made a very public... Continue Reading →